Clinical trial
Children's Autism Metabolome Project
NCT02548442 · Stemina Biomarker Discovery, Inc., Industry · Unknown status
Key facts
| NCT number | NCT02548442 |
|---|---|
| Title | Children's Autism Metabolome Project |
| Official title | Children's Autism Metabolome Project (CAMP): Development and Clinical Evaluation of the Stemina Metabolic Biomarker-Based Test to Diagnose Autism Spectrum Disorder in Early Childhood |
| Acronym | CAMP-01 |
| Lead sponsor | Stemina Biomarker Discovery, Inc., Industry |
| Collaborators | National Institute of Mental Health (NIMH) NIH Nancy Lurie Marks Family Foundation |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Autism Spectrum Disorder, Developmental Disorder |
| Enrollment | 1,102 |
| Start date | Aug 1, 2015 |
| Primary completion | Jan 1, 2023 |
| Completion | Aug 1, 2023 |
| First posted | Sep 14, 2015 |
| Last update posted | Jun 29, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: